VU

Valence8 US Portfolio holdings

AUM $238M
This Quarter Return
+5.83%
1 Year Return
+14.65%
3 Year Return
5 Year Return
10 Year Return
AUM
$229M
AUM Growth
+$229M
Cap. Flow
+$26.2M
Cap. Flow %
11.43%
Top 10 Hldgs %
96.09%
Holding
56
New
31
Increased
3
Reduced
4
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VIR icon
26
Vir Biotechnology
VIR
$686M
$252K 0.1%
+33,650
New +$252K
BPMC
27
DELISTED
Blueprint Medicines
BPMC
$242K 0.1%
+2,618
New +$242K
RARE icon
28
Ultragenyx Pharmaceutical
RARE
$2.89B
$236K 0.1%
+4,241
New +$236K
ENTA icon
29
Enanta Pharmaceuticals
ENTA
$180M
$207K 0.09%
+19,939
New +$207K
RLAY icon
30
Relay Therapeutics
RLAY
$619M
$185K 0.08%
+26,200
New +$185K
ZVRA icon
31
Zevra Therapeutics
ZVRA
$509M
$150K 0.06%
+21,596
New +$150K
ERAS icon
32
Erasca
ERAS
$445M
$128K 0.05%
+46,923
New +$128K
SLDB icon
33
Solid Biosciences
SLDB
$427M
$110K 0.05%
+15,728
New +$110K
VTGN icon
34
VistaGen Therapeutics
VTGN
$102M
$103K 0.04%
+34,376
New +$103K
ZURA icon
35
Zura Bio
ZURA
$133M
$71K 0.03%
+17,495
New +$71K
ALEC icon
36
Alector
ALEC
$238M
$68.5K 0.03%
+14,708
New +$68.5K
CLYM
37
Climb Bio, Inc. Common Stock
CLYM
$151M
$61.3K 0.03%
+12,045
New +$61.3K
LPTX icon
38
Leap Therapeutics
LPTX
$12M
$47.6K 0.02%
+18,511
New +$47.6K
NKTR icon
39
Nektar Therapeutics
NKTR
$568M
$33.9K 0.01%
+26,107
New +$33.9K
KZR icon
40
Kezar Life Sciences
KZR
$28.9M
$16.3K 0.01%
+21,136
New +$16.3K
ALT icon
41
Altimmune
ALT
$338M
0
AMGN icon
42
Amgen
AMGN
$155B
0
APLS icon
43
Apellis Pharmaceuticals
APLS
$3.48B
0
APLT icon
44
Applied Therapeutics
APLT
$71M
0
AVDL
45
Avadel Pharmaceuticals
AVDL
$1.43B
0
AZN icon
46
AstraZeneca
AZN
$248B
0
BCRX icon
47
BioCryst Pharmaceuticals
BCRX
$1.74B
0
CCCC icon
48
C4 Therapeutics
CCCC
$185M
0
CLDX icon
49
Celldex Therapeutics
CLDX
$1.47B
0
CRSP icon
50
CRISPR Therapeutics
CRSP
$4.71B
0